Membrane estrogen receptor (mER)

Membrane estrogen receptors (mERs) are a group of cell surface receptors that mediate the rapid, non-genomic signaling actions of estrogens, distinct from the classical effects of nuclear estrogen receptors. The most well-characterized mER is the G protein-coupled estrogen receptor (GPER, also known as GPR30), but other mERs include ER-X, Gq-mER, and variant forms of ERα and ERβ that become membrane-associated through post-translational modifications[1][9]. mERs can activate a variety of intracellular signaling cascades—including those involving protein kinase A, protein kinase C, and MAPK—thereby modulating processes such as cellular proliferation, neuronal excitability, and gene expression through indirect mechanisms[1]. These receptors are therapeutically relevant: they play important roles in endocrine function, cardiovascular health, cancer biology, and neuroprotection[1][8][4]. Many selective estrogen receptor modulators (SERMs), such as tamoxifen and fulvestrant, interact with both nuclear and membrane ERs, displaying tissue- and cell-type dependent agonism or antagonism[7][8]. mERs contribute to the complexity of estrogen signaling and are increasingly recognized as significant therapeutic targets in estrogen-related diseases, especially in hormone-dependent cancers and metabolic or inflammatory conditions[4][7][8].

Other names

Membrane ERmERsG protein-coupled estrogen receptor (GPER or GPR30)ER-XGq-mERGPRC6AERx

Agonist-mediated activation of rapid intracellular signaling (MAPK, PKA, PKC activation), Modulation of G-protein coupled receptor pathways, Desensitization of GABA_B receptor coupling, Selective estrogen receptor modulation (SERM—antagonist/agonist effects in a tissue-specific manner)